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background: Sperm banking is recommended for all men before cancer treatment, which carries a risk of long-term gonadal damage.
However, relatively few men take up the offer. Among them, few attend for fertility monitoring or agree to sperm disposal where fertility
recovers sperm banks are therefore burdened by long-term storage of samples that may not be needed for conception, with implications for
healthcare resources. The aims here were to determine the views of men regarding personal beneﬁts of sperm banking, and the advantages
and disadvantages of fertility monitoring and disposal in the longer term.
methods: Semi-structured interviews were conducted with 19 men who were diagnosed with cancer and had banked sperm at least 5
years previously. Men were asked to recall their experiences from diagnosis to the present time, focusing on the consequences for their
fertility. Interviews were transcribed and analysed using Interpretative Phenomenological Analysis.
results: Results are discussed in relation to decisions surrounding banking sperm, fertility monitoring and attitudes to disposal of banked
sperm. Complex attitudes were identiﬁed, with men’s views reﬂecting their understanding of their current and future fertility and the possible
trajectory of cancer itself. Men are overwhelmed by information on diagnosis and fail to understand the implications of cancer treatment for
their future fertility.
conclusions: On diagnosis, men are given large amounts of information about cancer and treatment but fail to understand the longer-
term implications of sperm banking. These implications need to be speciﬁcally addressed at subsequent appointments in order to optimize
fertility monitoring and timely disposal of sperm samples.
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Introduction
Sperm banking is recommended for all males prior to cancer treat-
ment where there is a risk of long-term gonadal damage (Royal
College of Physicians, 2007). However, uptake is lower than expected
given the incidence of cancer in men of reproductive age (Meseguer
et al., 2006), even in the UK where sperm banking is invariably pro-
vided free of charge (National Collaborating Centre for Women’s
and Children’s Health, 2004).
Among those who do bank sperm, very few respond to invitations
to review fertility (Tomlinson and Pacey, 2003) or attempt to use
banked sperm in assisted reproduction techniques (ARTs) (Pacey,
2007) even though successful pregnancies have been achieved after
sperm have been stored for 28 years (Feldschuh et al., 2005).
Banked sperm can be used in intrauterine insemination if post-thaw
sperm quality is high, or IVF or ICSI if post-thaw sperm quality is
poor (Wallace et al., 2005; Pacey, 2007).
Previous reports and guidelines (National Collaborating Centre for
Women’s and Children’s Health (2004) and Royal College of Phys-
icians (2007) offer little guidance on the long-term management of
men with banked sperm and provide no advice concerning the pro-
vision and frequency of post-treatment fertility testing (semen analy-
sis). Regular semen analysis following cancer treatment might be
considered good medical practice because it provides information
about changes in fertility that can facilitate decisions about the appro-
priate use of contraception or expedite referral for ART. However,
semen analysis now also fulﬁls an important part of the UK regulatory
process.
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In the UK, sperm can remain banked for a maximum of 55 years if
consent is renewed every 10 years if ‘signiﬁcant or premature inferti-
lity’ is demonstrated (Human Fertilisation and Embryology Authority,
2009). In practice, this means that where men cannot be contacted,
or refuse to renew consent or return for fertility testing, banked
sperm must be destroyed when consent expires. Hallak et al.
(1998) found that the number of samples discarded is low (8–24%),
usually following death or recovered fertility; and relatively few men
agreed to elective disposal. Consequently, sperm banks are currently
burdened by long-term storage of samples that may not be needed for
conception, with considerable implications for healthcare resources.
For all these reasons, questions have been raised about ‘unnecessary’
referral to the service (Magelssen et al., 2005).
Most previous work in this area has focused on men’s decisions on
whether or not to bank sperm on diagnosis of cancer (Achille et al.,
2006; Chapple et al., 2007; Wilkes et al., 2010). Evidence suggests
that men who are younger, better educated and childless (Schover
et al., 2002), single (Girasole et al., 2006) and optimistic (Achille
et al., 2006) are more likely to bank sperm. Banking has been associ-
ated with positive emotional functioning in the face of cancer diagnosis
(Saito et al., 2005). Fears that banking might delay life-saving treatment
(Schover et al., 1999) and worries about abnormalities in children born
from frozen sperm (Lass et al., 2001) have been cited as reasons why
men decline. While contributing to our understanding of why men
agree or refuse to bank sperm, this research offers little insight into
the subsequent decisions about fertility monitoring or sperm disposal
in the longer term, yet for those in charge of sperm banks, it is equally
important to understand the latter decisions.
In this paper, we describe a preliminary study to further our under-
standing of men’s decisions surrounding banking sperm and speciﬁcally
their subsequent views concerning fertility monitoring and sperm dis-
posal. This was prompted by the growing size of sperm banks, the
management costs associated with running them and the recent
changes to the UK regulatory framework (Human Fertilisation and
Embryology Authority, 2009), which gives increasing importance to
fertility monitoring. These longer-term decisions are much less well
understood compared with those made on diagnosis, even though
they have considerable consequences for the men themselves, their
families and delivery of care.
Materials and Methods
Recruitment and sample
Forty-four patients were invited to participate by post, and a further 15
when attending a routine appointment at the sperm bank for fertility
testing. In our practice, patients are sent a letter every 2 years to invite
them to attend for fertility testing/monitoring (semen analysis), renew
their consent or give permission for disposal of banked samples. Men
were sequentially selected from those who responded to this letter
during the July 2008 to September 2010 period. Each patient was provided
with an information sheet about the study and asked to sign and return a
consent form in a pre-paid envelope if they were interested in participat-
ing. The Trent Research Ethics Committee (Ref: 07/H0405/61) approved
all recruitment procedures.
As recommended in conducting qualitative research, we aimed to
achieve sample diversiﬁcation (Laperrie`re, 1997): a representative
sample of cancer patients at different stages of the disease and recovery.
We therefore adopted broad inclusion criteria, including: (i) currently aged
18–55 years; (ii) sperm banked prior to gonadotoxic treatment for cancer;
(iii) sperm in storage for more than 5 years; (iv) no known mental health
problems and (v) English language competence sufﬁcient to be
interviewed.
Of the 59 patients approached, 26 (45%) agreed to take part and inter-
views were subsequently arranged by telephone. However, analysis
suggested that no new information emerged following the initial 19 inter-
views and it was therefore assumed that data saturation had been reached
at this stage.
Data collection and analysis
Semi-structured interviews explored men’s experiences leading up to the
diagnosis of cancer, and their understanding of cancer treatment and its
impact on their fertility. The interviews were organized around the follow-
ing topics: (i) recall of banking sperm on diagnosis; (ii) follow-up after treat-
ment, (including fertility monitoring and experience of attending Oncology
follow-up) and (iii) attitudes to disposal of stored samples. Interviews were
conducted by trained interviewers (E.A.C. and C.E.), and took place in
participants’ homes (n ¼ 15) or the university (n ¼ 4).
Interviews lasted on average 60 min and were audio-taped, transcribed
verbatim and analysed using interpretive phenomenological analysis (IPA)
(Smith et al., 2009). IPA was developed speciﬁcally to elicit an individual’s
subjective experience and the associated cognitions and emotions of an
experience of importance. IPA is a data-driven analysis that facilitates
identiﬁcation of themes within and across interviews.
Six transcripts were independently coded by two researchers and differ-
ences resolved by discussion. This enabled the coders to address any
inconsistencies at an early stage in the analysis and establish a robust
coding frame. The remainder (n ¼ 13) of the interviews were coded by
one researcher and checked by the second coder (n ¼ 6).
Results
Demographic and disease-related characteristics of the men inter-
viewed are reported in Table I and fertility-related and follow-up
characteristics in Table II. The analysis of the interviews is organized
around three main themes: (i) decisions surrounding banking sperm;
(ii) fertility monitoring and (iii) attitudes to disposal of banked
sperm. Each included a number of subthemes. Examples of comments
from patients for each theme and subtheme are given in Table III.
Decisions surrounding banking sperm
Men discussed their decisions about banking in relation to ﬁve sub-
themes: experiences prior to diagnosis, information on diagnosis, future fer-
tility, family support and role of the oncologist.
Men’s views about banking sperm need to be seen against the back-
ground of their experiences prior to diagnosis. For many, there was a
long period of uncertainty before the diagnosis either because men
themselves failed to take symptoms seriously or because doctors
were unable to conﬁrm the diagnosis. In these cases, a cancer diagno-
sis, even though it was frightening, suggested a course of action and
possible cure. Given the protracted diagnosis, it should not be surpris-
ing that men were often reluctant to bank sperm before beginning
treatment. They wanted to start treatment as soon as possible and
were concerned that banking would result in unnecessary delay,
with adverse implications for survival.
Most men were overwhelmed by the amount of information on diag-
nosis. This inevitably focused on cancer and the proposed treatment
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and, as a result, men were often unclear about the implications of
treatment for their future fertility. Half of the men in this study recalled
being very pessimistic on diagnosis about the chances of any recovery
of fertility: for these men, banking sperm provided a safety net, an
assurance of a ‘normal life’ following treatment.
The decision to bank sperm was sometimes facilitated by partners
or parents and, in the case of the youngest patients, their fathers, indi-
cating the importance of family support but all emphasized the role of
the oncologist in providing information. The oncologist was also vital
since they were in a position to facilitate appointments and ensure
that sperm banking did not delay the overall treatment plan. Men
accepted the oncologist’s advice and kept appointments at the
sperm bank in the same way as they kept appointments for other
aspects of their treatment care plan, such as blood tests and scans.
Without this very practical support, many would not have organized
sperm banking themselves. An over-riding theme in all interviews was
the extent to which men went along with whatever they were advised
to do. At the same time, they lacked any clear understanding about
how cancer treatment might affect their fertility and therefore the
potential importance of sperm banking. Furthermore, they did not
appreciate how their fertility might change in the future, how they
would set about using banked sperm if necessary, or critically their
obligation to make subsequent decisions about fertility monitoring,
and ongoing sperm storage and disposal.
Fertility monitoring
All men interviewed had attended for semen analysis at least once
(Table II), usually when they were establishing a new relationship or
planning to start a family. Men were divided as to whether they saw
fertility monitoring as an intrusion into everyday life, and non-
attendance was often a result of anxiety about current fertility.
Others saw fertility monitoring as an opportunity much as they did
oncology follow-up. For all men, information about recovered fertility
was very important, not least because it contributed to feelings of
restored masculinity.
For many, post-treatment fertility monitoring was not seen to be
important, partly because they did not realize that fertility could
recover after treatment ends. Consequently, it was simply an intrusion
into everyday life, a lot of bother for no real purpose and a reminder of
past illness. Men felt uneasy about telling others they were attending
fertility monitoring and were reluctant to ask employers for time off
work. Some described not liking the jokes and suggestions of compro-
mised masculinity that typically followed explaining to others.
The most common reason for non-attendance was anxiety about
current fertility. Others wanted to ‘give something back’ to the hospital:
they attributed their survival to medical experience accrued through
treatment of previous patients and wanted to contribute themselves
to better care in the future by attending when asked. The presence
of a parent/partner was important, or they came because they
wanted to talk through the implications of disposal. Men chose not
to attend rather than be told their fertility was sub-optimal.
Others saw fertility monitoring as an opportunity with the hope for
reassurance, much as they did for oncology follow-up. Oncology
follow-up was seen to be more valuable by all although attitudes to
attendance were complex (feelings that appointments were more
beneﬁcial for medical professionals than men themselves, guilt at
taking up time that could be better spent with newly diagnosed
patients, dislike of being reminded of their illness) but these negative
emotions were never a barrier to attendance. Even ‘bad news’ at
........................................................................................
Table I Demographic and disease-related
characteristics of the participating men (n 5 19) who
were diagnosed with cancer.
Participant characteristics
Age at diagnosis (mean, range) 27.8 (15–41 years)
Age at interview (mean, range) 36 (22–40 years)
Time since sperm banking in years (mean, range) 8.3 (5–13 years)
Diagnosis
Testicular cancer 7 (38%)
Hodgkin’s lymphoma 5 (26%)
Non-Hodgkin’s lymphoma 1 (5%)
Leukaemia 5 (26%)
Ewing’s Sarcoma 1 (5%)
Marital status
Married/living with partner 16 (84%)
Partner but not living together 2 (11%)
Single 1 (5%)
Qualiﬁcations
None/secondary school certiﬁcates 8 (42%)
University degree 11 (58%)
Employment status
Work full-time 13 (68%)
Work part-time/student 2 (11%)
Homemaker/unemployed/on sick leave 4 (21%)
........................................................................................
Table II Fertility-related and follow-up characteristics
of participants.
Participant characteristics
Number of times attended Andrology clinic (mean, range) 2.5 (1–6)
Current fertility (based on WHO, 1999 classiﬁcation)
Fertile 6 (32%)
Subfertile 6 (32%)
Azoospermic 7 (37%)
Attempted ART after treatment 7 (37%)
Currently have children 10 (53%)
Conceived naturally pre-diagnosis 4 (21%)
Conceived naturally post-treatment 1 (5%)
Conceived through ART 3 (16%)
Adopted children 1 (5%)
Children with donor sperm 1 (5%)
Agreed to dispose of banked sperm 5 (26%)
Currently attending Oncology follow-up 12 (63%)
WHO, World Health Organization; ART, assisted reproduction techniques.
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Table III Descriptions of individual themes used in the analysis [patient reference number, age (years) at sperm banking]
and examples of comments made by participants.
(i) Decisions surrounding banking sperm
Experiences prior to
diagnosis
I think what it is when you’re ﬁrst diagnosed your world falls apart. You can’t think of anything but that and then because you don’t
know how bad it’s going to be and after that you have a number of tests. Because initially they said a bit of radiotherapy on your
neck and you’ll probably be alright. Then they found it on my chest and round my stomach and then it goes from a bit of
radiotherapy to chemo. So through that time it is obviously quite difﬁcult and you don’t know what’s going to come next. What
they’re going to ﬁnd next. You don’t know anything about the treatment. But then once it gets to kind of the bottom when they
have diagnosed it completely then they start talking about the treatment and you know you start feeling better because you feel as
though you’re actually recovering doing something about curing it as opposed to it’s been diagnosed and not having any treatment
but just ﬁnding out that things are getting worse and worse and worse. (01,35)
Information on diagnosis I didn’t really put 2 and 2 together no. And I suppose I didn’t till after, even afterwards I didn’t realize what affect it would have. I’m
sure they must have explained it but whether I’d got too much on or whether I just didn’t understand or whether I just didn’t realize,
I don’t know. (03,33)
Future fertility I mean one of the things I regret was the sort of erm . . . my attitude that I will never have children again. Whether it wasn’t
explained to me ever good enough or I just didn’t listen when I was told but the whole situation whereby my sperm count could
improve naturally anyway, I didn’t really ever have that in my mind. So in terms of using contraception and that sort of thing that was
something I was probably quite ignorant about. (20,30)
Family support I didn’t want to do it at all. Just because I didn’t want to go through the process, just because I was so embarrassed basically. But my
dad forced me to, well not physically forced me to but just said come on you’ve got to do it. Extremely embarrassed about that
concept in front of my parents. (04,14)
I can remember sort of when I then got dropped off and knew for sure sort of meeting down the street and seeing her coming up
and you know sort of telling her straight away. I think [my partner] was prepared in that way so it wasn’t quite a shock where
suddenly she was very upset. I think she’d sort of steeled herself to that and I think she’d decided that she would play the very
positive role to try and support me you know to say that it would all be alright and you know we’d get through the treatment and
things like that, together. (13,25)
Role of the oncologist There wasn’t really the time, it was sort of, I don’t know how long before possibly, from being diagnosed it was maybe, it wasn’t the
following day it would probably be the day after, so I think within a couple of days they’d arranged for me to go and give a sample
because obviously I was anaemic and I was so poorly they wanted to get on with the treatment as quickly as possible, so it was over a
couple of days so I don’t think therewas the time really to speak, it was never, it was never a decision really, it was automatic. (07,18)
(ii) Fertility monitoring
Intrusion into everyday life Oh yeah I’ll go to that, left it on the side anyway four weeks went by and I thought I haven’t got time to do that, I’ll leave it which
were bad of me I admit, but again, I’ve got a busy life and I’ve got a job to do and you know it wasn’t the most pressing thing on my
mind. Don’t know what changed my mind this time, like I say I wanted to know for my own piece of mind to see whether or not my
fertility had dropped or it had improved, that type of thing, so that’s why I went in this time. (09,21)
Anxiety about current
fertility
I think deep in the back of my mind I always at least hoped that it would come back and you can kind of see from the pattern of my
kind of . . . I went back and had my fertility tested quite a few times probably 3, 4 years after my chemo in the kind of hope that it
would come back and then kind of gave up. (09,21)
Opportunity I would like to get to the point one day where you wouldn’t need or you wouldn’t have to need the sperm in storage, you know that
eventually it would come back naturally on its own. So you wouldn’t need to go through the assisted conception treatment. In
terms, for me, I’ve always been interested in going back and I think more so recently because we were looking at starting at family,
that there’s was always the option that can we try naturally rather than have to go back and go through the treatment. So it’s been
more of an interest to go and ﬁnd out more off my own back than probably being nudged by the hospital saying a year’s passed do
you want to come back and see if there’s any change. (01,18)
Oncology follow-up I like the reassurance and that I know I can go in 3 months time. I can say to someone ‘I’m a bit worried about this’ or ‘can you just
check the scar’. Its nice to have that contact. Its almost like you need that momentum that bit of contact serves to keep you going
and ticking over.’ cos you worry you know? oh its come back. So its nice to have the contact. (15,23)
Feelings of masculinity In terms of being infertile I think there’s an effect there that probably, maybe not feel less of a man, but when you see either
different, not comedy sketches or different references to being infertile, you kind of silently not feel that that’s aimed at you but
there’s that kind of thought, it’s almost that that’s me but nobody knows about it. So I think you’d probably feel more masculine if I
was more fertile. I think it’s something I’ve never really thought about in that sense, I don’t feel totally alienated because I’m infertile
but I think subconsciously somewhere there’s always that thought. (19,21)
(iii) Attitudes to disposal
Fear of disease recurrence I much prefer the idea of it being kept indeﬁnitely. I think it’s a security blanket thing and I sort of relate it back to like going for the
follow up appointments. Actually when they turned round and said this is your last appointment, we won’t need to see you again,
you actually felt quite . . . you felt a little bit concerned and worried about that cos you know it was sort of a security blanket and you
were going back each year and you know you felt like it was being watched and I think that’s the same with the sperm sample. Even
though there’s no really rational reason for keeping sperm samples that are not probably quite as good as the quality of what you’re
producing now it’s a security blanket and it sort of re-assures you and makes you feel a bit more secure I suppose and crudely
thinking as well, well if something unexpected happened to me quickly, if I died, for you know whatever, obviously there’s no cost to
me to keep it indeﬁnitely, it’s a resource issue for the andrology people. (13,25)
Continued
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oncology follow-up had some compensation (early detection might
lead to better outcomes). Men realized that ‘bad news’ about fertility
carried no such possibilities. Information about recovered fertility was
welcome even among men who did not want any more children, since
it restored feelings of masculinity and enabled them ‘to draw a line’
under the whole illness experience.
Attitudes to disposal
The most common argument used to justify continued storage was
fear of disease recurrence, although there were psychological beneﬁts
for those who were able to agree to disposal and put the illness
experience in perspective. Men also discussed the fate of banked
samples.
Five men had agreed to dispose of their banked sperm by the time
of this study; three because their fertility had recovered, one had
adopted children and one because he believed his banked sperm
was too poor to use in ART. The remaining 14 men (including
fertile and infertile men) were undecided about whether or not to
agree to disposal.
Decisions about disposal were complex and unresolved but often
centred around fear of disease recurrence. Typically, where fertility
had recovered, men saw stored samples as a psychological protection
against fertility decline in the event of future disease; for these men,
disposal would amount to ‘tempting fate’. Some men who were cur-
rently subfertile or azoospermic thought that they would agree to dis-
posal if their fertility recovered but were not prepared to do this
prematurely. There were deﬁnite psychological beneﬁts for those who
were able to take the decision that stored samples were not
needed. These men were able to put the whole cancer experience
behind them and ‘move on’.
In contrast to the complexity surrounding decisions about sperm
disposal, many men found it relatively easy to decide about the fate
of banked samples in the event of their death or mental incapacity,
in that they were content to leave the sample for their partner and
allow her to make the decision. Difﬁculties arose for those who did
not have a partner or had separated from the person who they had
initially named on the consent form. In these cases, they were con-
cerned that samples might be used against their wishes. Others who
were concerned about cancer recurrence and premature death
were prepared for their samples to be destroyed, as they did not
want their children to grow up without a father. Three men were
also willing for their sperm to be used for research.
Discussion
Our results extend previous work focusing on the decision to bank
sperm on diagnosis of cancer to include attitudes towards fertility
monitoring and disposal of banked sperm in the longer term.
The barriers that men experience on diagnosis that might account
for the relatively low uptake of sperm banking have been described
previously, and include anxiety to initiate treatment as soon as poss-
ible, given fears that delays could compromise treatment efﬁcacy
(Chapple et al., 2007). This anxiety was common among all those
who took part in this study but our data suggest that the wish to
begin treatment as soon as possible is partly a consequence of the
relatively long period of illness and anxiety before diagnosis. In this
context, the wish to simply get on with treatment rather than worry
about future fertility is understandable.
Most men described how, prior to banking sperm, oncologists
initiated discussions about the possibility of compromised fertility
and the options available. However, the oncologists not only provided
information but also facilitated and co-ordinated appointments with
the sperm bank. The oncologist did not simply recommend sperm
banking; they assumed responsibility for most aspects of organization.
The presence of a parent or partner was also invaluable. This corro-
borates the ﬁndings of Achille et al. (2006) and might suggest that
single men, or those who attend Oncology alone, may need more sen-
sitive counselling and professional support.
On diagnosis of cancer, men in our study were focused on treatment
and recovery rather than whether or not they might want children in the
future, with considerable implications for how they engage with post-
treatment fertility monitoring programmes. The low take-up of post-
treatment fertility monitoring has previously been attributed to men’s
reluctance to know the state of their fertility (Wasserman et al.,
1987; Chapple et al., 2007) and our data also suggest that news of
poor semen quality post-treatment is distressing, even where sperm
of adequate quality has been banked. However, men were largely
unaware that fertility may recover after cancer treatment and therefore
saw little reason to attend for semen analysis. The probability of reco-
vering spermatogenesis post-treatment is largely disease- and
treatment-speciﬁc. Over 60% of those who banked sperm can show
some sperm production after 3 years follow-up (Bahadur et al.,
2005). Such information needs to be explained more carefully to men
as this may help them to engage in the process of fertility monitoring.
All those interviewed were anxious about attending fertility moni-
toring for fear of being told their fertility was poor. It might seem
Table III Continued
Psychological beneﬁts I think the main thing I would sum up with is that the point that I’ve reached now, having been through cancer treatment, IVF,
banking sperm and so, I’ve reached a very positive frame of mind where I can see all those experiences as very meaningful but have
reached the point where I do not want to used the banked sperm any more so that has perhaps become something that I’m going
to leave behind now. (15,23)
Fate of banked samples Well obviously next of kin. If she wanted to. If she didn’t then she could cancel it if you know what I mean. It would have been her
decision anyway In a few years time she might meet somebody else, marry and have kids with them and then it’s a whole new life.
Even though it’s the life she’s had before she’s not experienced having kids with that person. And in a way I suppose it’s not luggage
in a way because whereas if I was poorly and you’d got that chance to have them if they pass away, a bit like that Diane Blood
woman, then she’s got that option then. She can do it if she wants. But then she can say well hang about he’s gone I want to have a
fresh start, cancel them. Because nobody else is going to get to use them. (14,25)
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that men are unconcerned about their fertility and not interested in
keeping appointments, but we suggest instead that they harbour real
fears about fertility loss, partly because the results of semen analysis
were often an integral part of men’s assessment of their general
health and recovery from cancer.
The question of disposal of banked sperm was highly complex.
Those whose fertility had recovered were often reluctant to dispose
of sperm even when they considered their families complete. This
was related in part to fear of disease recurrence and knowledge
that this could lead to renewed fertility loss. This wish to keep
samples in storage was strong and overrode an awareness of the
resource implications of doing so.
Men’s concerns about sperm disposal share some similarities with
the views of couples who struggle to know what to do with cryopre-
served embryos that remain at the end of IVF treatment (Provoost
et al., 2009). Frozen embryos have been viewed as: (i) biological
tissue; (ii) virtual children with interests in need of protection and nur-
turing; (iii) siblings of living children and (iv) genetic or psychological
insurance policies and symbolic reminders of past infertility (Newton
et al., 2007), perhaps with different implications for decisions about
disposal. This work, suggesting why individuals may ﬁnd decisions to
dispose of embryos to be difﬁcult, may provide important insights
into why men are reluctant to dispose of banked sperm, even when
it is no longer useful.
Limitations
Qualitative research is often criticized given the small samples typically
recruited and reliability of the data analysis; both have implications for
the generalizability of results. To address this, we followed key criteria
for quality qualitative work (Smith, 2011) and these included recruit-
ment of a sample including a wide age-range, differing in the number
of previous children and frequency of attending clinic. However,
there is a bias in our sample, especially towards more educated
men who presumably had more ﬂexibility in their work to arrange
appointments and perhaps felt more comfortable discussing these
issues with a researcher.
As in any research study, our results are dependent on the experi-
ences of those men who agreed to take part. There may be many
reasons why men chose not to take part in this study (e.g. work com-
mitments, no current concerns about fertility) and it has been noted
previously that many men fail to maintain contact with the sperm
bank in the years following banking (Tomlinson and Pacey, 2003). It
is important to obtain the views of these men as this may increase
our understanding of why many samples are stored needlessly (and
expensively for the Health Service).
Interviews were conducted with men from a single sperm bank
located within easy reach of the local cancer hospital, where most
oncologists were well informed and positive towards sperm banking.
However, some oncologists may be more reluctant than others to
discuss sperm banking (Schover et al., 2002) and it is possible that
our results reﬂect the unique arrangements in Shefﬁeld Teaching Hos-
pitals, and need to be conﬁrmed elsewhere.
Finally, the quality of this kind of work is dependent on the skills of
the interviewer (Smith, 2011) and it might be argued that the discus-
sion of male fertility would be most successful when conducted by
male interviewers. However, there is evidence that female
interviewers create conditions that are more conducive to disclosure,
and are perceived as more sympathetic than male interviewers
(Pollner, 1998). In practice, all the interviews were lengthy and
involved, and there was no suggestion that men felt compromised
by female interviewers. Efforts were made to ensure the reliability
of the data, in that two researchers with experience of the method
agreed on the deﬁnition of themes.
Our results are limited to understanding men’s views about fertility
preservation and may not be relevant to women who are faced with
cancer treatment. Such issues of reduced fertility also confront
women, although routine egg preservation has only become available
comparatively recently (Gosden, 2005), meaning that less is known
about female attitudes to fertility preservation. The procedures associ-
ated with embryo and ooctye cryopreservation can take several
weeks, which may lead to a signiﬁcant delay in cancer therapy and
potentially a problem for those with advanced-stage cancers (West
et al., 2009). Evidence currently available suggests that young
women are interested in options to help preserve fertility during
cancer treatments but, like men, they are not willing to postpone
treatment for this purpose (Burns et al., 2006). In the future, it may
be helpful to conduct research that addresses differences between
men and women in the value they place on fertility preservation
prior to beginning cancer treatment.
Clinical implications
When banking sperm, men routinely described how the oncologist
was central to information-giving and facilitated the whole process
of banking. Men in this study, who had all banked sperm on diagnosis,
appreciated that sperm banking was made easy for them in that the
oncology department organized many appointments. As such they
described how they simply went along with routine clinical advice
rather than spent time weighing up the pros and cons of banking.
The implication might be that where, for whatever reason, there is
poor communication between Oncology and the sperm bank, or
physical separation between departments, men may be less likely to
bank, irrespective of their own beliefs or wish for children in the
future. Previous research also suggests that oncologists vary in their
views about the value of sperm banking and the extent to which
they are prepared to, or conﬁdent about, discussing this with men
(Quinn et al., 2009).
Given that oncology departments organize sperm banking and that
men are given so much information on diagnosis, it is not surprising
that they fail to understand why they are banking sperm or how this
might affect their future. Consequently, men often had little infor-
mation about the advantages of routine fertility monitoring, the prob-
ability of their fertility recovering or an understanding of the options
for conception using banked samples. Men in our study reported
being overwhelmed by the amount of information given on diagnosis,
much of which was not fully assimilated. It is clear that they typically
did not fully understand how fertility might be affected by cancer treat-
ment, the likely course of any fertility recovery, or implications for use
of stored samples in the event of their death. Provision therefore
needs to be made for more detailed discussions about the longer-
term implications of sperm storage, after men have recovered from
the initial trauma of diagnosis and understanding cancer treatment.
The optimum timing and approach for this needs to be established
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but discussions could take place as an integral part of any formal dis-
charge from Oncology.
The ability to reproduce is central to heterosexual masculine iden-
tity (Gurevich et al., 2004) and is especially important when there is a
threat to life (Fritsche et al., 2007). Opportunities to bank sperm
where fertility is challenged by cancer or its treatment therefore
potentially offer men signiﬁcant improvements in quality of life. As
questions are raised about the costs involved in keeping sperm
banked, it is essential to understand men’s apparent reticence to be
involved in fertility monitoring or agree to disposal. This reticence
may reﬂect men’s well-documented lack of interest in health care
(White and Banks, 2004) and health-related research (Moynihan,
1998Q1 ). We would argue more than this: such reticence is related to
complex fears about compromised fertility and what this might indi-
cate about disease recurrence.
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